Tripos looks to the future with Pharsight acquisition
Drug discovery informatics and services provider, Tripos International, has agreed to buy Pharsight Corporation, a provider of software and strategic services for clinical drug development.
Archives for September 10, 2008
Parexel feels effects of adding ClinPhone
Parexel has trimmed back its earnings guidance for the first quarter of fiscal 2009 as it starts the process of integrating ClinPhone, which the company bought for £91m (€114m) last month.
Le Fur flies as GSK exec made Sanofi CEO
GlaxoSmithKline’s head of North American operations, Chris Viehbacher, is to takeover as chief operating officer (CEO) at Sanofi-Aventis after he missed out on the top spot at GSK last year.
BioReliance expands to keep pace with GeneTox demand
BioReliance has had to significantly expand its Rockville, US, facility and hire new staff in order to accommodate the growing demand for its genetic toxicology (GeneTox) testing services.
CFC-free compliance a "blessing in disguise"
As the December 31 deadline for the removal of CFC albuterol inhalers in the US approaches, a new report by Kalorama Information forecasts big changes in the global $36bn (€26bn) a year respiratory products market.
Phase I outsourcing to India by 2010?
The outsourcing of Phase I trials to India may be allowed by 2009-10 after the Central Drugs Standard Control Organisation (CDSCO) said it is considering changing its stance.
CSL begins this year’s Alfuria shipments
CSL Biotherapies, part of Australia’s CSL group, has begun shipping the first of six million doses of its thimerosal-free vaccine Afluria to the US CDC ahead of this year’s flu season.
Residual solvents guidelines cause ANDA “uncertainty”
Companies have failed to provide the information needed under the USP’s new chapter regarding residual solvents, causing them to incorrectly file ANDAs, according to the Office of Generic Drugs (OGD).